Extended Release Protein for Nutrition
What You Need to Know Before You Apply
What is the purpose of this trial?
The overall goal of this study is to determine the minimum dose required to elicit measurable elevation of plasma essential amino acid levels 12 hours after consuming VitaKey's extended release protein technology. The results of this study will be used to set a dose for future protein clinical studies.
Are You a Good Fit for This Trial?
This trial is for healthy men and women aged 18-40 with a BMI of 20-28. Participants must not use tobacco or nicotine, agree to follow study rules, sign consent forms, and have good vein access for blood draws. They can't have health issues that would interfere with the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive different doses of VitaKey's extended release protein technology to determine the minimum dose required for measurable elevation of plasma essential amino acid levels
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Extended Release Nutritional Protein
Trial Overview
The study tests VitaKey's extended release protein to find the smallest dose that raises essential amino acid levels in the blood after 12 hours. It compares this new protein form against a control group and different dosages.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
VitaKey Inc.
Lead Sponsor
United States Department of Defense (DOD)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.